Related Content
May 11, 2017 — Biotronik announced U.S. Food and Drug Administration (FDA) approval of the company's MultiPole Pacing ...
May 10, 2017 — Biotronik announced the availability of the first U.S. Food and Drug Administration (FDA)-approved ...
May 9, 2017 — Biotronik announced U.S. Food and Drug Administration (FDA) approval and the launch of Sentus ProMRI, the ...
April 28, 2017 — Biotronik’s Pulsar-18 bare metal stent (BMS) has yielded high primary patency in a real-world setting ...
April 12, 2017 — Biotronik announced the European launch of a new lead for tachycardia therapy that features a helical ...
March 23, 2017 — Biotronik announced the European launch of the Edora series, its smallest series of pacemakers and ...
March 22, 2017 — Patients with recurrent fainting episodes (syncope) who received a pacemaker delivering a pacing ...
February 15, 2017 — The PRO-Kinetic Energy Cobalt Chromium (CoCr) Coronary Stent System from Biotronik has gained U.S ...
February 14, 2017 — Biotronik has developed an online tool that streamlines the workflow for physicians selecting the ...
January 20, 2017 — Biotronik has enrolled the first patients in the BioInsight clinical study evaluating the safety and ...